Favorable response to nivolumab in sarcomatoid malignant pleural mesothelioma: A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Favorable response to nivolumab in sarcomatoid malignant pleural mesothelioma: A case report

Published:2022-03 Issue: Volume:5 Page:100138
ISSN:2666-6219
Container-title:Current Problems in Cancer: Case Reports
language:en
Short-container-title:Current Problems in Cancer: Case Reports

Author:

Kunishige Michihiro,Kondo Yoshihiro,Kadota Naoki,Okano Yoshio,Machida Hisanori,Hatakeyama Nobuo,Hino Hiroyuki,Naruse Keishi,Shinohara Tsutomu,Sakiyama Shoji,Takeuchi Eiji

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study;Treasure;Lancet Oncol.,2011

2. The MARS feasibility trial: conclusions not supported by data;Weder;Lancet Oncol.,2011

3. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma;Ceresoli;J. Clin. Oncol.,2006

4. Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies;Pistolesi;Chest,2004

5. Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials;Mansfield;Lung Cancer,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unexplained Pleural Effusion Leads to the Revelation of a Malignant Mesothelioma: A Case Report;Cureus;2022-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP